Digestive System Lymphoma

hematologic malignancy

Identifier: CI-CAN-00000817
Entity page: /cancer/digestive-system-lymphoma ↗
Edges: 180

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Digestive System Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 61show all (up to 200)
→ investigated in trials for	Cyclophosphamidesmall molecule 16 trials (3 active) · roll-up of the cancer and its descendants	—	—	Digestive System Lymphoma	16	Observed	clinicaltrials	graph →
→ investigated in trials for	Etoposidesmall molecule

Digestive System Lymphoma studied in …STUDIED_INderived10 of 119show all (up to 200)
→ studied in	NCT07583810Phase 2 · recruiting Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma · condition mapped ONTOLOGY_EXACT · 119 trials mapped (17 active)	—	—	Gastric Mucosa-Associated Lymphoid Tissue Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06454149recruiting Cohort Study for Gastric MALT Lymphoma · condition mapped ALIAS · 119 trials mapped (17 active)	—	—	Gastric Mucosa-Associated Lymphoid Tissue Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04115631Phase 2 · active not recruiting A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 119 trials mapped (17 active)	—	—	Liver Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04803201Phase 2 · recruiting Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 119 trials mapped (17 active)	—	—	Enteropathy-Associated T-Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07388563Phase 1 · suspended Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 119 trials mapped (17 active)	—	—	Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07055477Phase 1 · recruiting A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL) · condition mapped ONTOLOGY_EXACT · 119 trials mapped (17 active)	—	—	Hepatosplenic T-Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03113500Phase 2 · active not recruiting Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 119 trials mapped (17 active)	—	—	Enteropathy-Associated T-Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05377827Phase 1 · suspended Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 119 trials mapped (17 active)	—	—	Enteropathy-Associated T-Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07691450Phase 1 · not yet recruiting Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma · condition mapped CURATED_BROADER · 119 trials mapped (17 active)	—	—	Enteropathy-Associated T-Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01815749Phase 1 · active not recruiting Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma · condition mapped ALIAS · 119 trials mapped (17 active)	—	—	Small Intestinal Lymphoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains